Pharma Focus Asia
Eppendorf Bioprocess Solutions

AbCellera Opens New GMP Manufacturing Facility in Canada


AbCellera plans to open Good Manufacturing Practices (GMP) manufacturing facility. The first-of- its-kind facility will be located in Canada.


The new 130,000-square-foot GMPN facility will be constructed on a current vacant two-acre site. Moreover, this expansion will increase the capabilities of bringing new antibody therapies to clinical trialsand thus supportsquickly to future pandemics.

The new construction will expand capabilities in developing new antibody therapies. Moreover, the planned building will house space for warehousing, GMP protein biologic manufacturing, laboratory and office.

The construction of the facility is scheduled for later this year. It is expected that the new facility will be ready for GMP manufacturing in early 2024.

The manufacturing facility is funded by US$125.6million grant from the Canadian government’s Strategic Innovation Fund (SIF).

The new construction will addhundrends of highly skilled scientific employees to its existing workforce of nearly 300 people in the coming years.


TypeNew Construction
Latest Issue
Get instant
access to our latest e-book
THERMOFISHER SEACPHI Korea 2023Bora Pharmaceutical - A robust approach to analytical testing is essentialSelangor International Expo MEDIC 2023TFS - Webinar - DynaSpin™ Single-Use Centrifuge for harvest applicationsMedical Fair Thailand 2023ThermoFisher Scientific - NEW Mobile AppCPHI & PMEC China 20233rd ANNUAL COMPUTER SOFTWARE ASSURANCE 2023Pharma Regulatory Conclave 202320th Anniversary Hospitalog Asia 2023
Charles River Laboratories - Endosafe Compendial LAL Cartridge Technology